Guided Therapeutics (GTHP) Return on Sales Growth (1y) (2011 - 2025)
Guided Therapeutics (GTHP) Return on Sales Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | 0.00 |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 0.00 |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | 0.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 0.00 |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 | 650.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 650.00 |
| Sep 30, 2025 | 44.00 |
| Jun 30, 2025 | 50.00 |
| Mar 31, 2025 | -2,375.00 |
| Dec 31, 2024 | -640.00 |
| Sep 30, 2024 | 18.00 |
| Jun 30, 2024 | -22.00 |
| Mar 31, 2024 | -28.00 |
| Dec 31, 2023 | 322.00 |
| Sep 30, 2023 | 293.00 |
| Jun 30, 2023 | 150.00 |
| Mar 31, 2023 | 62.00 |
| Dec 31, 2022 | -327.00 |
| Sep 30, 2022 | -371.00 |
| Jun 30, 2022 | 332.00 |
| Mar 31, 2022 | -67.00 |
| Dec 31, 2021 | -94.00 |
| Sep 30, 2021 | -17.00 |
| Jun 30, 2021 | -337.00 |
| Mar 31, 2021 | -91.00 |